← Back to patent-cliff list
Cefcamate Pivoxil Hydrochloride
Tier C — Watch / tradeCefcamate Pivoxil Hydrochloride
Shionogi & Co., Ltd.
Originator
1997
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PBPs
Brand：Flomox, Flumax
Indications (approved)：Bacterial infection
Regional status
US
-
EU
-
China
Approved
2010-12-31
Japan
Approved
1997-06-01
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Cefcamate Pivoxil Hydrochloride?
Approved indications include: Bacterial infection.
When does the Cefcamate Pivoxil Hydrochloride patent expire?
No public expiry year is available for Cefcamate Pivoxil Hydrochloride yet; this page updates once verified.
How do I get a quote for Cefcamate Pivoxil Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27